Fell Donald G. 4

4 · Aspire Biopharma Holdings, Inc. · Filed Jun 6, 2025

Insider Transaction Report

Form 4
Period: 2025-06-04
Transactions
  • Purchase

    Common Stock, par value $0.0001

    2025-06-04$0.39/sh9,500$3,7059,500 total
  • Purchase

    Common Stock, par value $0.0001

    2025-06-05$0.39/sh10,500$4,09520,000 total

Documents

1 file
  • 4
    ownership.xmlPrimary